Gulf International Bank UK Ltd decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 5,555 shares of the biotechnology company’s stock after selling 213 shares during the period. Gulf International Bank UK Ltd’s holdings in Axon Enterprise were worth $2,219,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Motley Fool Asset Management LLC increased its holdings in Axon Enterprise by 238.7% in the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after purchasing an additional 346,838 shares during the last quarter. 1832 Asset Management L.P. bought a new position in Axon Enterprise during the first quarter worth about $81,630,000. International Assets Investment Management LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth about $871,860,000. Vanguard Group Inc. increased its stake in shares of Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after acquiring an additional 212,401 shares during the last quarter. Finally, Swedbank AB acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $39,923,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on AXON. Northland Securities lifted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. JMP Securities increased their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC increased their target price on Axon Enterprise from $400.00 to $525.00 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd. Finally, Bank of America assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $380.00 target price on the stock. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $392.85.
Axon Enterprise Stock Up 4.2 %
Axon Enterprise stock opened at $459.52 on Thursday. The company has a fifty day simple moving average of $405.32 and a 200 day simple moving average of $343.13. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 1-year low of $212.88 and a 1-year high of $462.64. The company has a market cap of $34.73 billion, a P/E ratio of 121.25, a price-to-earnings-growth ratio of 10.99 and a beta of 0.94.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the previous year, the business earned $0.80 earnings per share. Axon Enterprise’s quarterly revenue was up 34.5% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.
Insider Buying and Selling at Axon Enterprise
In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the sale, the director now directly owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 25,811 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the sale, the president now owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 371,172 shares of company stock worth $137,000,162 over the last ninety days. 5.70% of the stock is currently owned by corporate insiders.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- What a Trump Win Looks Like for the Market Now and Into 2025
- How to Invest in the Best Canadian StocksĀ
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What Are Dividend Challengers?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.